A Quick Updated Review of Lidocaine in Dentistry

Background: The amino amide type, lidocaine, lignocaine with the brand name Xylocaine, which was discovered in 1946 and went on sale in 1948, is a local anesthetic agent. Lidocaine is the most widely used medication in dentistry. The aim of this study was to provide an updated review regarding lidocaine as a local anesthesia in dentistry. Methods: The appropriate documents for this review were achieved by searching databases such as; Web of Science, Scopus, and PUBMED. From their inception to 14 May 2024 based on the relevant and in-depth search, current, high-quality manuscripts were selected. Results: It is well known that before dental operation, lidocaine may be given to the patient. Unlike general anesthesia, lidocaine does not cause the feeling of being asleep condition in a patient. A recent publication confirmed that by attention to microbial contamination, multi-dose vials could be used in clinics for economic reasons. Based on the nation, gender, age, weight, and medical condition of the patients the maximum recommended dose of lidocaine could be varied. Regarding allergic reactions in a dental office, dentists should quickly manage anaphylaxis and associated events. In addition, the publication confirmed that bupivacaine may be superior to lidocaine with epinephrine and mepivacaine with regard to time and amount of analgesic consumption. Conclusion: A protected and consistent pain supervision procedure in the field of dentistry could be mentioned as local analgesia. The use of modern techniques could make the process more enjoyable for both the dentist and the patient.